News | Latest Breaking News Stories & Headlines

Jeremy Skillington is the CEO of Poolbeg Pharma

Open Orphan's Poolbeg Pharma to list on London's AIM

Pharmaceutical firm Open Orphan has today announced plans to spin out a Dublin-headquartered company focused on infectious diseases, called Poolbeg Pharma.

Business • 17 Jun

Cathal Friel, executive chairman of Open Orphan

Open Orphan considers spinning out assets

Specialist pharmaceutical services clinical research company, Open Orphan, is considering a possible spin-out of certain non-core development intellectual property assets.

Business • 13 Apr

Cathal Friel, executive chairman at Open Orphan

Volunteers complete 'quarantine phase' of Covid study

Dublin-listed pharmaceutical company Open Orphan has said the first three volunteers have now successfully completed the quarantine phase of their 'Covid-19 characterisation study' with no ...

Business • 25 Mar

Cathal Friel, Open Orphan's executive chairman

Open Orphan agrees Covid contract with UK government

Dublin-listed pharmaceutical company Open Orphan said its subsidary hVIVO has agreed a deal with the UK government to develop a Covid-19 human challenge study model.

Business • 20 Oct 20

Open Orphan wins new £4.3m challenge study deal

Dublin-listed pharmaceutical company Open Orphan has announced a new £4.3m contract to conduct a human viral challenge study using one of its eight traditional challenge ...

Business • 28 Sep 20

Open Orphan signs €4.4m contract with global company

Pharmaceutical services company, Open Orphan has signed a new contract, valued at €4.4m, with a global pharmaceutical company to provide a respiratory syncytial virus (RSV) ...

Business • 10 Aug 20

Open Orphan agrees contract for Covid-19 vaccine trial

Dublin-listed pharmaceutical company Open Orphan has announced a new contract with Codagenix to conduct a first human trial evaluating safety and immunogenicity of a single-dose ...

Business • 28 Jul 20

Cathal Friel, the executive chairman of Open Orphan

Open Orphan agrees option to buy CHIMagents

Dublin-listed pharmaceutical services group Open Orphan has signed an option to buy a company called CHIMagents. The company designs and makes "challenge agents", which are ...

Business • 15 Jul 20

Open Orphan said it saw unprecedented growth opportunities as pharma focuses funding on Covid-19 and respiratory diseases

Open Orphan develops challenge study model for vaccines

Dublin listed pharmaceutical company Open Orphan has said it is developing the world's first challenge study model to test the effectiveness of a number of ...

Business • 24 Jun 20

Open Orphan provides tests vaccines and antivirals for other pharmaceutical firms

Open Orphan raises £12m for Covid-19 testing

Irish pharmaceutical firm Open Orphan has raised £12m, which it will put towards the hunt to find a vaccine for Covid-19.

Business • 22 May 20

Open Orphan also announced today that it has signed a new contract with an unnamed US biotechnology company

Open Orphan CEO to leave the company

Chief executive of specialist pharmaceutical company, Open Orphan, Trevor Phillips is to leave the firm, it has been announced.

Business • 04 May 20

Open Orphan to buy hVIVO in £30m merger deal

Irish pharmaceutical firm Open Orphan has agreed to a merger deal with British firm hVIVO, which would create a group valued at around £30m.

Business • 09 Dec 19

Search RTÉ.ie

Cant find what you're looking for?